Retina Subspecialty Day 2: AI Session Highlights

Dr. J. Peter Campbell, Chair of the Academy Committee on Artificial Intelligence, shares highlights from the artificial intelligence session he moderated during Retina Subspecialty Day 2. Key topics included deep learning in MacTel Type 2, OCT-based biomarkers for neovascular AMD and geographic atrophy, automated diabetic retinopathy screening, and ChatGPT in the modern retina practice.

Financial Disclosures: Dr. J. Peter Campbell discloses financial relationships with Boston AI Labs (Consultant/Advisor); Genentech, National Eye Institute, Research to Prevent Blindness (Grant Support); Siloam Vision (Owner).